{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:15:01Z","timestamp":1791918901044,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Vaxart Inc."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.vaccine.2018.05.112","type":"journal-article","created":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T17:26:27Z","timestamp":1528565187000},"page":"4265-4277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats"],"prefix":"10.1016","volume":"36","author":[{"given":"Christina","family":"Joyce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran D.","family":"Scallan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Belshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean N.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne C.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.05.112_b0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40266-015-0258-9","article-title":"Respiratory syncytial virus infection in older adults: an under-recognized problem","volume":"32","author":"Branche","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/j.vaccine.2018.05.112_b0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/irv.12234","article-title":"Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults","volume":"8","author":"Widmer","year":"2014","journal-title":"Influenza Resp Vir"},{"key":"10.1016\/j.vaccine.2018.05.112_b0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/infdis\/jis309","article-title":"Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults","volume":"206","author":"Widmer","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.112_b0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1586\/14760584.2014.878653","article-title":"Current concepts and progress in RSV vaccine development","volume":"13","author":"Guvenel","year":"2014","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2018.05.112_b0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1442-200x.2004.01860.x","article-title":"Role of serum neutralizing antibody in reinfection of respiratory syncytial virus","volume":"46","author":"Kawasaki","year":"2004","journal-title":"Pediatr Int"},{"key":"10.1016\/j.vaccine.2018.05.112_b0030","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.112_b0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.05.112_b0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.05.112_b0045","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.05.112_b0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/421524","article-title":"Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults","volume":"190","author":"Walsh","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.112_b0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4049\/jimmunol.107.1.123","article-title":"Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness","volume":"107","author":"Mills","year":"1971","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.05.112_b0060","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.201412-2256OC","article-title":"Impaired antibody-mediated protection and defective IgA B-Cell memory in experimental infection of adults with respiratory syncytial virus","volume":"191","author":"Habibi","year":"2015","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.vaccine.2018.05.112_b0065","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/infdis\/jiv281","article-title":"Effect of preexisting serum and mucosal antibody on experimental respiratory syncytial virus (RSV) challenge and infection of adults","volume":"212","author":"Bagga","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.112_b0070","doi-asserted-by":"crossref","first-page":"37295","DOI":"10.1038\/srep37295","article-title":"Systemic and mucosal immune responses following oral adenoviral delivery of influenza vaccine to the human intestine by radio controlled capsule","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2018.05.112_b0075","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S1473-3099(15)00266-2","article-title":"High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial","volume":"15","author":"Liebowitz","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.112_b0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/CVI.00552-12","article-title":"An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models","volume":"20","author":"Scallan","year":"2013","journal-title":"Clin Vacc Immunol"},{"key":"10.1016\/j.vaccine.2018.05.112_b0085","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.vaccine.2013.01.023","article-title":"Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-gamma T cell responses in humans","volume":"31","author":"Peters","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.112_b0090","doi-asserted-by":"crossref","first-page":"e50852","DOI":"10.1371\/journal.pone.0050852","article-title":"Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats","volume":"7","author":"Smith","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.05.112_b0095","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/jvi.61.10.3163-3166.1987","article-title":"Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity","volume":"61","author":"Johnson","year":"1987","journal-title":"J Vir"},{"key":"10.1016\/j.vaccine.2018.05.112_b0100","first-page":"347","article-title":"The cotton rat Sigmodon hispidus model of respiratory syncytial virus infection","volume":"372","author":"Boukhvalova","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2018.05.112_b0105","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1099\/0022-1317-82-12-2881","article-title":"Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine","volume":"82","author":"Prince","year":"2001","journal-title":"J Gen Vir"},{"key":"10.1016\/j.vaccine.2018.05.112_b0110","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.vaccine.2013.11.032","article-title":"A recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein\/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathology","volume":"32","author":"Blanco","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.112_b0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2018.05.112_b0120","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1016\/j.vaccine.2010.07.068","article-title":"Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1","volume":"28","author":"Sealy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.112_b0125","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1128\/JVI.02191-08","article-title":"Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunity","volume":"83","author":"Pasetti","year":"2009","journal-title":"J Vir"},{"key":"10.1016\/j.vaccine.2018.05.112_b0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1258\/002367702320389026","article-title":"Diversifying animal models: the use of hispid cotton rats (Sigmodon hispidus) in infectious diseases","volume":"36","author":"Niewiesk","year":"2002","journal-title":"Lab Anim"},{"key":"10.1016\/j.vaccine.2018.05.112_b0135","first-page":"771","article-title":"The pathogenesis of respiratory syncytial virus infection in cotton rats","volume":"93","author":"Prince","year":"1978","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2018.05.112_b0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0264-410X(91)90151-U","article-title":"Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV)","volume":"9","author":"Murphy","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.112_b0145","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/jmv.22134","article-title":"Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children","volume":"83","author":"Freitas","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2018.05.112_b0150","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1016\/j.vaccine.2014.09.030","article-title":"An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization","volume":"32","author":"Raghunandan","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.112_b0155","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/mt.2013.142","article-title":"Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation","volume":"22","author":"Johnson","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2018.05.112_b0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.vaccine.2013.11.013","article-title":"Synergistic induction of interferon alpha through TLR-3 and TLR-9 agonists stimulates immune responses against measles virus in neonatal cotton rats","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.112_b0165","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.vaccine.2012.11.009","article-title":"Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine","volume":"31","author":"Glenn","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.112_b0170","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1128\/JVI.03194-13","article-title":"Development of an adenovirus-based respiratory syncytial virus vaccine: preclinical evaluation of efficacy, immunogenicity, and enhanced disease in a cotton rat model","volume":"88","author":"Kim","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.05.112_b0175","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1525-0016(03)00180-1","article-title":"Systemic and mucosal antibody responses following retroductal gene transfer to the salivary gland","volume":"8","author":"Tucker","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2018.05.112_b0180","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/cid\/ciu507","article-title":"Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines","volume":"59","author":"Radin","year":"2014","journal-title":"Clin Infec Dis Off Publ Infec Dis Soc Am"},{"key":"10.1016\/j.vaccine.2018.05.112_b0185","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1016\/S0264-410X(03)00355-4","article-title":"Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies","volume":"21","author":"Piedra","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.112_b0190","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","author":"The-IMpact-RSV-Study-Group","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.05.112_b0195","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1038\/ncomms9143","article-title":"A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism","volume":"6","author":"Krarup","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2018.05.112_b0200","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.05.112_b0205","doi-asserted-by":"crossref","first-page":"e71072","DOI":"10.1371\/journal.pone.0071072","article-title":"A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles","volume":"8","author":"Rigter","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.05.112_b0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2004.04.005","article-title":"Experimental infection of humans with A2 respiratory syncytial virus","volume":"63","author":"Lee","year":"2004","journal-title":"Antivir Res"},{"key":"10.1016\/j.vaccine.2018.05.112_b0215","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/infdis\/174.2.256","article-title":"Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection","volume":"174","author":"Weltzin","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.112_b0220","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0022-3476(94)70186-5","article-title":"Economic impact of viral respiratory disease in children","volume":"124","author":"Meissner","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2018.05.112_b0225","first-page":"171","article-title":"Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus","volume":"12","author":"Valosky","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2018.05.112_b0230","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1586\/14760584.7.1.25","article-title":"Oral adenoviral-based vaccines: historical perspective and future opportunity","volume":"7","author":"Tucker","year":"2008","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.vaccine.2018.05.112_b0235","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jcla.20172","article-title":"Improved method to calculate the antibody avidity index","volume":"21","author":"Perciani","year":"2007","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.vaccine.2018.05.112_b0240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jim.2003.12.015","article-title":"Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system","volume":"286","author":"Crotty","year":"2004","journal-title":"J Immunol Meth"},{"key":"10.1016\/j.vaccine.2018.05.112_b0245","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jim.2013.02.009","article-title":"Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses","volume":"391","author":"Jahnmatz","year":"2013","journal-title":"J Immunol Meth"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:27:36Z","timestamp":1759400856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18307898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":49,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0264410X18307898"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.112","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}